KBC Group NV has increased its holdings in
ResMed Inc. (RMD). Apart from this, there has been a momentum behind
RMD as a long-term growth stock. Some concerns have been raised regarding the CEO's compensation. The company announced its first quarter results for fiscal year 2025. It has been suggested that
ResMed stock still has room to grow, and
Entropy Technologies LP invested $1.87 million in RMD.
Baillie Gifford & Co. lowered its stake in the company whereas Sumitomo Mitsui Trust Group Inc. increased its stock holdings. Despite the concerns regarding insiders selling stocks, analyst upgrades and street-beating Q1 results have been optimistic indicators for the stock. The company's consistent returns on capital are not to be overlooked. RMD expects to grow its earnings, which adds to its allure as a growth stock. However, some holdings were lowered, like
Los Angeles Capital Management LLC. The strong financial performance of the company in Q1 has been a talking point. Overall, the supporters of RMD believe it offers good growth opportunities in the long run while acknowledging individual concerns and changes within the market.
Resmed RMD News Analytics from Mon, 24 Jun 2024 07:00:00 GMT to Sat, 16 Nov 2024 11:08:08 GMT -
Rating 8
- Innovation 4
- Rumor 5
